Effect of soy isoflavones on blood pressure: A meta-analysis of randomized controlled trials

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 6, 2012, Pages 463-470

  Liu, X X ^a,b   Li, S H ^a,b   Chen, J Z ^a   Sun, K ^a   Wang, X J ^a   Wang, X G ^a,b   Hui, R T ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

Blood pressure; Hypertension; Meta analysis; Randomized controlled trial; Soy isoflavones

Indexed keywords

ISOFLAVONE DERIVATIVE; PLANT EXTRACT;

ARTICLE; BLOOD PRESSURE; CALORIC INTAKE; CHEMISTRY; DRUG EFFECT; FACTUAL DATABASE; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOYBEAN;

BLOOD PRESSURE; DATABASES, FACTUAL; ENERGY INTAKE; HUMANS; ISOFLAVONES; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOYBEANS;

EID: 84861201786     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.09.006     Document Type: Article

References (31)

1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42:1206-1252.
2. McInnes G.T. Lowering blood pressure for cardiovascular risk reduction. J Hypertens 2005, (23(Suppl):S3-S8.
3. Appel L.J., Brands M.W., Daniels S.R., Karanja N., Elmer P.J., Sacks F.M. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006, 47:296-308.
4. Sacks F.M., Lichtenstein A., Van Horn L., Kris-Etherton P., Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006, 113:1034-1044.
5. Mahn K., Borras C., Knock G.A., Taylor P., Khan I.Y., Sugden D., et al. Dietary soy Isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. Faseb J 2005, 19:1755-1757.
6. Squadrito F., Altavilla D., Squadrito G., Saitta A., Cucinotta D., Minutoli L., et al. Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res 2000, 45:454-462.
7. Teede H.J., Dalais F.S., Kotsopoulos D., Liang Y.L., Davis S., McGrath B.P. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001, 86:3053-3060.
8. Hermansen K., Sondergaard M., Hoie L., Carstensen M., Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 2001, 24:228-233.
9. Jayagopal V., Albertazzi P., Kilpatrick E.S., Howarth E.M., Jennings P.E., Hepburn D.A., et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002, 25:1709-1714.
10. Rivas M., Garay R.P., Escanero J.F., Cia P., Cia P., Alda J.O. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 2002, 132:1900-1902.
11. Sagara M., Kanda T., Jelekera M.N., Teramoto T., Armitage L., Birt N., et al. Effects of Dietary intake of soy protein and isoflavones on cardiovascular disease risk factors in high risk, middle-aged men in Scotland. J Am Coll Nutr 2004, 23:85-91.
12. Cuevas A.M., Irribarra V.L., Castillo O.A., Yanez M.D., Germain A.M. Isolated soy protein improves endothelial function in postmenopausal Hypercholesterolemic women. Eur J Clin Nutr 2003, 57:889-894.
13. Puska P., Korpelainen V., Hoie L.H., Skovlund E., Knut T. Isolated soya protein with standardised levels of isoflavones, cotyledon soya fibres and soya phospholipids improves plasma lipids in hypercholesterolaemia: a double-blind, placebo-controlled trial of a yoghurt formulation. Br J Nutr 2004, 91:393-401.
14. Hermansen K., Hansen B., Jacobsen R., Clausen P., Dalgaard M., Dinesen B., et al. Effects of soy supplementation on blood lipids and arterial function in Hypercholesterolaemic subjects. Eur J Clin Nutr 2005, 59:843-850.
15. Kreijkamp-Kaspers S., Kok L., Bots M.L., Grobbee D.E., Lampe J.W., van der Schouw Y.T. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr 2005, 81:189-195.
16. He J., Gu D., Wu X., Chen J., Duan X., Chen J., et al. Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann Intern Med 2005, 143:1-9.
17. Teede H.J., Giannopoulos D., Dalais F.S., Hodgson J., McGrath B.P. Randomised, controlled, cross-over trial of soy protein with isoflavones on blood pressure and arterial function in hypertensive subjects. J Am Coll Nutr 2006, 25:533-540.
18. Zhan S., Ho S.C. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 2005, 81:397-408.
19. Taku K., Umegaki K., Ishimi Y., Watanabes S. Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: metaanalysis of randomized controlled trials. Ther Clin Risk Manag 2008, 4:1097-1103.
20. Taku K., Umegaki K., Sato Y., Taki Y., Endoh K., Watanabe S. Soy isoflavones lower Serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 2007, 85:1148-1156.
21. Clarkson T.B. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 2002, 132:566S-569S.
22. Moher D., Pham B., Jones A., Cook D.J., Jadad A.R., Moher M., et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998, 352:609-613.
23. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
24. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
25. Egger M., Davey Smith G., Schneider M., Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
26. Morgan T.O., Anderson A.I., MacInnis R.J. ACE inhibitors, betablockers, calcium blockers, and diuretics for the control of systolic hypertension. Am J Hypertens 2001, 14:241-247.
27. Li S.H., Liu X.X., Bai Y.Y., Wang X.J., Sun K., Chen J.Z., et al. Effect of oral isoflavone Supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am J Clin Nutr 2010, 91(2):480-486.
28. Yeboah J., Crouse J.R., Hsu F.C., Burke G.L., Herrington D.M. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the cardiovascular health study. Circulation 2007, 115:2390-2397.
29. Ward N.C., Croft K.D., Hodgson J., Rich L., Beilin L.J., Puddey I.B. Brachial artery Vasomotor function is inversely associated with 24-h ambulatory blood pressure. J Hypertens 2004, 22:967-972.
30. Watson T., Goon P.K., Lip G.Y. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. Antioxid Redox Signal 2008, 10:1079-1088.
31. Nasca M.M., Zhou J.R., Welty F.K. Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol 2008, 102:84-86.